A Study of the Sleepnet Elara APAP Device
Part of paid clinical trials in Auburn, Alabama.
- Sponsor
- Sleepnet Corporation
- Study ID
- NCT07559708
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Sleep Apnea - Obstructive
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sleepnet Elara Treatment — DEVICESubject to have a 1 night in-lab PSG
Study Details
The goal of this study is to evaluate the effectiveness of the Elara APAP device.
Key Dates
- Start date
- Apr 27, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 55 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentSleepnet Elara Treatment
Primary Outcome Measure
AHI 4% [ Time Frame: Day 1 ]
Central Contacts
- Andrea Brown, M.S.408-881-2611
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Sleep Disorders Center | Auburn | Alabama | 36832 | Anthony McLeod, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Auburn, AL
By research site